APOE4 Status and cognitive function in middle-aged and elderly people
By:
References
- J. Kim, J. M. Basak, and D. M. Holtzman, “The Role of Apolipoprotein E in Alzheimer’s Disease,” Neuron. 2009; 63(3): 287–303,
- O. MC, M. SE, Z. G, N. AC, and M. CE, “APOE genotype and cognition in healthy individuals at risk of Alzheimer’s disease: A review,” Cortex. 2018; 104: 103–123.
- G. Jun et al., “Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region,” Arch Neurol. 2012; 69(10): 1270–1279.
- L. A. Farrer et al., “Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis,” JAMA. 1997; 278(16): 1349–1356.
- S. M. Laws, E. Hone, S. Gandy, and R. N. Martins, “Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription,” J. Neurochem. 2003; 84(6): 1215–1236.
- S. Emrani, H. A. Arain, C. DeMarshall, and T. Nuriel, “APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review,” Alzheimers. Res. Ther. 2020; 12(1): 141.
- R. Cacciaglia et al., “Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer’s disease,” Alzheimer’s Dement. 2018; 14(7): 902–912.
- K. Chen et al., “Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares,” Neuroimage. 2012; 60(4): 2316.
- A. Montagne et al., “APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline,” Nature. 2020; 581(7806): 71–76.
- S. Moreno-Grau et al., “Exploring APOE genotype effects on AD risk and β-amyloid burden in individuals with subjective cognitive decline: The FACEHBI study baseline results,” 2017.
- World Medical Association, “Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols,” World Med. Assoc. 2013; 1964: 29–32.
- Diagnostic and statistical manual of mental disorders : DSM-IV. Fourth edition. Washington, DC : American Psychiatric Association, [1994] ©1994.
- M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician,” J. Psychiatr. Res. 1975; 12(3): 189–198.
- E. Strauss, E. M. S. Sherman, and O. Spreen, A compendium of neuropsychological tests: Administration, norms, and commentary, 3rd ed. New York, NY, US: Oxford University Press, 2006.
- A. Rey, “L’examen psychologique dans les cas d’encéphalopathie traumatique. (Les problems.). [The psychological examination in cases of traumatic encepholopathy. Problems.],” Arch. Psychol. (Geneve). 1941; 28: 215–285.
- Z. Shao, E. Janse, K. Visser, and A. S. Meyer, “What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults,” Front. Psychol. 2014; 5: 1–10.
- M. D. Lezak, D. B. Howieson, D. W. Loring, and J. S. Fischer, Neuropsychological assessment. Oxford University Press, USA, 2004.
- L. M. Nichols et al., “Interactive Effect of Apolipoprotein E Genotype and Age on Hippocampal Activation During Memory Processing in Healthy Adults,” Arch. Gen. Psychiatry. 2012; 69(8): 804–813.
- G. A. Rodriguez, M. P. Burns, E. J. Weeber, and G. W. Rebeck, “Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex,” Learn. Mem. 2013; 20(5): 256–266.
- T. Iachini, A. Iavarone, V. P. Senese, F. Ruotolo, and G. Ruggiero, “Visuospatial Memory in Healthy Elderly, AD and MCI: A Review,” Curr. Aging Sci. 2009; 2: 43–59.
- R. J. Piers, Y. Liu, T. F. A. Ang, Q. Tao, R. Au, and W. Q. Qiu, “Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study,” J. Alzheimer’s Dis. 2021; 80(3): 1269–1279.
- F. Mashayekhi, S. Sadigh-Eteghad, A. Naseri, M. Asadi, N. A. Garravnd, and M. Talebi, “ApoE4-positive multiple sclerosis patients are more likely to have cognitive impairment: a cross-sectional study,” Neurol. Sci. 2021. 2021; 1–8.
- I. Reinvang, T. Espeseth, and L. T. Westlye, “APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer’s disease,” Neurosci. Biobehav. Rev. 2013; 37: 1322–1335.
DOI: https://doi.org/10.2478/bjmg-2022-0012 | Journal eISSN: 2199-5761
Language: English
Page range: 13 - 18
Published on: Mar 1, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2023 N.A. Pavel, M.R. Paun, P.V. Matei, I. Dutu, C. Tudose, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.